Last updated on November 2018

A Pharmacokinetic Study of INCB018424 Phosphate Cream in Pediatric Subjects With Atopic Dermatitis


Brief description of study

The purpose of this study is to evaluate the safety, tolerability and the pharmacokinetics (PK) of topical INCB018424 cream applied to pediatric subjects (age 12 to 17 years) with atopic dermatitis (AD).

Clinical Study Identifier: NCT03257644

Contact Investigators or Research Sites near you

Start Over

Peck Ong

Children's Hospital of Los Angeles
Los Angeles, CA United States

Wynnis Tom

Rady Children's Hospital - San Diego
San Diego, CA United States

Donald Leung

National Jewish Health
Denver, CO United States

Amy Paller

Northwestern University Department of Dermatology
Chicago, IL United States

David Fivenson

David Fivenson, MD, Dermatology, PLC
Ann Arbor, MI United States

Adnan Nasir

Wake Research Associates
Raleigh, NC United States

Andrea Zaenglein

Penn State Hershey Medical Center
Hershey, PA United States

John Browning

Texas Dermatology and Laser Specialist Clinical Research
San Antonio, TX United States